The global mHealth market size reached USD 110.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 594.3 Billion by 2033, exhibiting a growth rate (CAGR) of 19.57% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 110.1 Billion |
Market Forecast in 2033
|
USD 594.3 Billion |
Market Growth Rate 2025-2033 | 19.57% |
Mobile health (mHealth) is a diversified branch of electronic health (eHealth) that collects patient data using mobile devices and wireless infrastructure. The collected data assists in obtaining accurate results that are utilized to treat and diagnose several medical conditions. mHealth assists in improving medication adherence and communication, allows remote patient monitoring and enables patients to send secure messages, connect to service providers and schedule appointments. As a result, it finds extensive application in healthcare supply chain management, diagnostic and treatment support, chronic disease monitoring and management and increasing health awareness among people. At present, mHealth technology is gaining popularity across the globe for home-based patient monitoring services among the geriatric population.
The rising dependence on mobile devices represents one of the key factors strengthening the global mHealth market growth. These devices enable individuals to access healthcare-related services via wireless multimedia easily. Moreover, mHealth solutions have user-friendly characteristics and offer efficiency during an emergency. This, in confluence with the increasing instances of chronic diseases, such as diabetes and hypertension, is positively influencing the market growth worldwide. Furthermore, the key manufacturers are integrating innovative technologies to support the healthcare industry, which, in turn, is fostering the market growth. For instance, the US Food and Drug Administration (FDA) announced the launch of an internet-based repository, CURE ID, in December 2019 that enabled the clinical community to report their experiences of treating infectious diseases with the existing FDA-approved drugs through smartphones, websites or other mobile devices.
IMARC Group provides an analysis of the key trends in each sub-segment of the global mHealth market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on component, service and participants.
Breakup by Component:
Breakup by Service:
Breakup by Participants:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Airstrip Technologies Inc., Allscripts Healthcare Solutions Inc., Apple Inc., Bayer Aktiengesellschaft, Boston Scientific Corporation, Koninklijke Philips N.V., Masimo Corporation, Omron HealthCare Inc. (OMRON Corporation), Qualcomm Incorporated, Samsung Electronics Co. Ltd. and Sanofi S.A.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Component, Service, Participants, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Airstrip Technologies Inc., Allscripts Healthcare Solutions Inc., Apple Inc., Bayer Aktiengesellschaft, Boston Scientific Corporation, Koninklijke Philips N.V., Masimo Corporation, Omron HealthCare Inc. (OMRON Corporation), Qualcomm Incorporated, Samsung Electronics Co. Ltd. and Sanofi S.A. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |